An optimally constrained V3 peptide is a better immunogen than its linear homolog or HIV-1 gp120
- 5 June 2010
- journal article
- Published by Elsevier BV in Virology
- Vol. 401 (2), 293-304
- https://doi.org/10.1016/j.virol.2010.03.007
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in ThailandThe New England Journal of Medicine, 2009
- Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitopeVirology, 2009
- High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccinationVirology, 2009
- Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbitsVirology, 2009
- Mimicking the Structure of the V3 Epitope Bound to HIV-1 Neutralizing AntibodiesBiochemistry, 2009
- Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificityVirology, 2008
- Structure determination of an anti-HIV-1 Fab 447-52D–peptide complex from an epitaxially twinned data setActa Crystallographica Section D-Structural Biology, 2008
- Structure of Antibody F425-B4e8 in Complex with a V3 Peptide Reveals a New Binding Mode for HIV-1 NeutralizationJournal of Molecular Biology, 2008
- Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodiesBiochemical Journal, 2006
- Molecular switch for alternative conformations of the HIV-1 V3 region: Implications for phenotype conversionProceedings of the National Academy of Sciences of the United States of America, 2006